US Patent Issued to Poseida Therapeutics on Oct. 6 for "Compositions and methods for the treatment of hemophilia" (California Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,753,418, issued on Oct. 6, was assigned to Poseida Therapeutics Inc. (San Diego).

"Compositions and methods for the treatment of hemophilia" was invented by Julian David Down (San Diego), Xinggang Liu (San Diego) and Jingjing Jiang (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to compositions and methods for the treatment of hemophilia. The compositions and methods can comprise an adeno-associated virus (AAV) piggyBac polynucleotide comprising a transgene. The transgene may comprise ornithine Factor VIII (FVIII) or Factor IX (FIX)."

The patent was filed on March 4, 2022, under Application No. 18/279,434.

*...